StartP8A • SGX
add
Cordlife Group Ltd
Seneste lukkekurs
0,16 $
Årsinterval
0,12 $ - 0,46 $
Markedsværdi
41,47 mio. SGD
Gns. volumen
24,84 t
P/E-værdi
-
Udbytteprocent
-
Primær børs
SGX
Markedsnyheder
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
| (SGD) | jun. 2024info | År til år-ændring |
|---|---|---|
Indtægt | 4,60 mio. | -67,54 % |
Driftsudgifter | 8,59 mio. | -6,80 % |
Nettoindtægt | -6,18 mio. | -655,33 % |
Overskudsgrad | -134,45 | -1.810,56 % |
Earnings per share | — | — |
EBITDA | -6,84 mio. | -615,37 % |
Effektiv afgiftssats | 8,73 % | — |
Årsbalance
Samlede aktiver
Samlede passiver
| (SGD) | jun. 2024info | År til år-ændring |
|---|---|---|
Kontanter og korttidsinvesteringer | 59,54 mio. | -15,89 % |
Samlede aktiver | 224,31 mio. | -4,16 % |
Samlede passiver | 101,27 mio. | 3,31 % |
Samlet egenkapital | 123,03 mio. | — |
Shares outstanding | 256,31 mio. | — |
Kurs/indre værdi | 0,32 | — |
Afkast af aktiver | -8,79 % | — |
Afkast af kapital | -15,66 % | — |
Pengestrøm
Nettoændring i likviditet
| (SGD) | jun. 2024info | År til år-ændring |
|---|---|---|
Nettoindtægt | -6,18 mio. | -655,33 % |
Pengestrøm fra drift | -2,95 mio. | -192,71 % |
Pengestrøm fra investering | 2,90 mio. | 258,76 % |
Pengestrøm fra finansiering | -549,50 t | -19,59 % |
Nettoændring i likviditet | -498,00 t | -153,06 % |
Fri pengestrøm | -4,65 mio. | -1.473,26 % |
Om
Incorporated in May 2001, Cordlife Group Limited, is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
The Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six key markets namely Singapore, Hong Kong, India, Indonesia and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers a comprehensive suite of diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
In January 2018, Cordlife acquired HealthBaby Biotech Co., Limited, the largest private cord blood bank in Hong Kong. Through its majority-owned subsidiary, Stemlife Berhad in Malaysia, Cordlife controls an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife is also the first Singapore private cord blood bank to provide cord blood and cord lining banking services in Myanmar and Vietnam. Wikipedia
Administrerende direktør
Grundlagt
2. maj 2001
Website
Ansatte
111
